Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison-Reference-Cited by-同舟云学术

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison

Published:2022-02 Issue: Volume:100 Page:103572
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Curtis Michael,Berk Justin,Larney Sarah,Rich Josiah D.,Stoové Mark

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference22 articles.

1. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release;Bird;Addiction,2015

2. Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers;Bucerius;International Journal of Drug Policy,2019

3. Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?;Carlson;International Journal of Drug Policy,2020

4. Public health alternatives to incarceration for drug offenders;Clark;Eastern Mediterranean Health Journal,2017

5. The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study;Degenhardt;Addiction,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the effectiveness of depot buprenorphine (buvidal injection) and buprenorphine/naloxone (suboxone) treatment following custody release - a retrospective cohort study;Journal of Substance Use;2024-04-28

2. Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study;Journal of Substance Use and Addiction Treatment;2023-07

3. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers;International Journal of Drug Policy;2022-12